| 发明名称 |
USE OF SOLUBLE FGL2 AS AN IMMUNOSUPPRESSANT |
| 摘要 |
<p>Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a soluble fgl2 protein or a nucleic acid encoding a soluble fgl2 protein. The methods are useful in preventing graft rejection, autoimmune disease, and allergies.</p> |
| 申请公布号 |
AU2003208197(A1) |
申请公布日期 |
2003.09.16 |
| 申请号 |
AU20030208197 |
申请日期 |
2003.02.28 |
| 申请人 |
TRILLIUM THERAPEUTICS INC. |
发明人 |
GARY LEVY |
| 分类号 |
A61K38/18;A61K38/36;A61K38/48;A61P37/06;C12N9/64;(IPC1-7):A61K38/00 |
主分类号 |
A61K38/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
